Glycemic ControlControl Group Usual Activity

Clinical evidence dossier

Control Group Usual Activity

Fasting Plasma Glucose (FPG)

Evidence signal

Evidence signal

Strong

This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.

Evidence snapshot

Authoritative support records
3
Supporting studies available for review
3
Randomized trials
3
Reported effects
6

Clinical conclusion

Control Group Usual Activity has not shown a clear effect on Fasting Plasma Glucose (FPG) in the available evidence.

The conclusion and evidence-signal classification are distinct authoritative fields and are reproduced as published.

Observed effects

Evidence composition

Non-randomized studies
0
Other designs
0
Unresolved designs
0
Magnitude-eligible effects
0

Consistency

Consistency classification

Consistent

Positive
0
No effect
3
Mixed
0
Negative
0

Population and applicability

Structured population data were available for 3 of 3 supporting studies. 1 study described participants with type 2 diabetes. 1 study described adult participants.

This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.

View reported population descriptions

These descriptions are reported across the supporting studies; they are not a single synthesized population.

  • Women diagnosed with type 2 diabetes.
  • Women with non-alcoholic fatty liver disease.
  • Overweight and obese pregnant women at risk for gestational diabetes.
  • Women seeking dietary interventions to manage weight gain during pregnancy.
  • Sedentary adults aged 30-65 years.
  • Individuals diagnosed with prediabetes.

Limitations

No structured limitations are available.

Supporting evidence

Inspect the authoritative studies and omitted support records for this dossier.

View supporting evidence